Blueprint Medicines to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass, March 20, 2014 (GLOBE NEWSWIRE) -- Blueprint Medicines today announced that members of the Company's senior management team will present at upcoming financial conferences:

BioCentury 21st Annual Future Leaders in the Biotech Industry Conference
Date: Friday, March 28, 2014
Time: 11:00 a.m. ET
Location: Millennium Broadway Hotel & Conference Center in New York, NY
Needham & Company 13th Annual Healthcare Conference
Date: Wednesday, April 9, 2014
Time: 11:40 a.m. ET
Location: Westin NY Grand Central Hotel in New York, NY

About Blueprint Medicines

Blueprint Medicines is a patient-focused biopharmaceutical company discovering and developing novel, highly-selective kinase inhibitors for genomically-defined patient populations with severe diseases. Led by a management team and advisors with world-renowned expertise in genomics-based drug discovery and development, Blueprint has built a platform that combines novel genomics with a novel chemical library of selective and highly potent kinase inhibitors. Founded in 2011, Blueprint is privately held and backed by Third Rock Ventures and Fidelity BioSciences. For more information, please visit

CONTACT: Kyle Kuvalanka (617) 714-6722 kkuvalanka@blueprintmedicines.comSource: Blueprint Medicines